Viewing Study NCT05644067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-02-28 @ 10:38 PM
Study NCT ID: NCT05644067
Status: COMPLETED
Last Update Posted: 2024-04-15
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Sponsor: Swiss Tropical & Public Health Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Plasmodium falciparum View
None MSP-1 View
None Tanzania View
None Phase Ib View
None Vaccine View
None GLA-SE View